Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-354 for asthma control in adults with uncontrolled moderate-to-severe persistent asthma
2008-007844-33Phase 2Completed
- Sponsor
- MedImmune
- Start
- Dec 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tralokinumab in asthma (4 arms), sponsored by MedImmune. Primary endpoint: Change from baseline in mean ACQ score at Study Day 92. Started Dec 2008; status: completed.
02
Drugs
tralokinumab
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-007844-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007844-33.